Yeah I noticed the over 3k posts on the AVXL board alone. Seems those holders are getting worried that Bryostatin might cut into the potential their drug might have. I realize Bryostatin is still a long shot but if its hits, avxl isn't in the same league as a simple "enhanced" treatment that is little better than current treatments. The one link I posted tonight answers any question about where the neurotrope science stands if the poster really wanted to know IMO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.